Aroa Biosurgery Limited (ARX) is a soft tissue regeneration company focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. It participates in the wound care and surgical reconstruction markets. Its products currently for sale in the key US market target chronic wounds and soft tissue reconstruction including, hernia, breast reconstruction and trauma/limb salvage/ tumour surgery.
Aroa Biosurgery
Follow
Get notifications in MyBN when activity occurs.
Company Activity
NEW ROLE: Catherine Mohr, Non-Executive Director | 11 Jul 2024 | |
NEW ROLE: Darla Hutton, Non-Executive Director | 11 Jul 2024 | |
NEW ROLE: Tracy Weimar, Joint Company Secretary | 03 Nov 2020 | |
NEW ROLE: John Diddams, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Philip McCaw, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Jim Mclean, Chief Financial Officer, Joint Company Secretary | 03 Nov 2020 | |
NEW ROLE: Steven Engle, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: John Pinion, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Brian Ward, Chief Executive, Managing Director | 03 Nov 2020 |